Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide fixed-dose combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Elvitegravir/Cobicistat/Emtricitabine/Tenofovir alafenamide fixed-dose combination, covering 2019-02-19 to 2019-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years [Phase 3]